Skip to main content
SpringerLink
Log in

Current and Novel Treatment Options for Actinic Keratosis

  • Published:
Journal of Cutaneous Medicine & Surgery

Abstract

Actinic keratosis (AK), located on sun-exposed areas of the skin, is an increasing global health burden. Multiple ablative and topical treatment options are available to manage this disease; however, topical treatment options are receiving significant interest because AK is commonly associated with areas of substantial photodamage, and destructive modalities cannot effectively treat subclinical AK. Several topical therapies, including 0.5% and other 5-fluorouracil concentrations, photodynamic therapy, 3% diclofenac sodium gel, and imiquimod 5% cream, are indicated in the treatment of AK. This article will review key data on the efficacy and safety of several topical therapies in the treatment and management of AK. The review includes discussions of imiquimod 5% cream, approved in 2004 in the treatment of AK of the face or scalp. Whether administered as monotherapy or adjunctive therapy, topical therapies provide the opportunity to effectively manage AK and will likely emerge as an important tool for healthcare providers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

FIGURE 1
FIGURE 2
FIGURE 3

Similar content being viewed by others

References

  • ES Smith SR Feldman AB Fleischer SuffixJr et al. (1998) ArticleTitleCharacteristics of office-based visits for skin cancer. Dermatologists have more experience than other physicians in managing malignant and premalignant skin conditions Dermatol Surg 24 981–985 Occurrence Handle10.1016/S1076-0512(98)00095-8 Occurrence Handle1:STN:280:DyaK1cvis1Kqtg%3D%3D Occurrence Handle9754086

    Article  CAS  PubMed  Google Scholar 

  • SR Feldman AB Fleischer SuffixJr RC McConnell (1998) ArticleTitleMost common dermatologic problems identified by internists, 1990-1994 Arch Intern Med 158 726–730 Occurrence Handle10.1001/archinte.158.7.726 Occurrence Handle1:STN:280:DyaK1c3htlequw%3D%3D Occurrence Handle9554678

    Article  CAS  PubMed  Google Scholar 

  • AA Memon JA Tomenson J Bothwell et al. (2000) ArticleTitlePrevalence of solar damage and actinic keratosis in a Merseyside population Br J Dermatol 142 1154–1159 Occurrence Handle10.1046/j.1365-2133.2000.03541.x Occurrence Handle1:STN:280:DC%2BD3cvgvFSjtA%3D%3D Occurrence Handle10848739

    Article  CAS  PubMed  Google Scholar 

  • YH Liao KH Chen MP Tseng et al. (2001) ArticleTitlePattern of skin diseases in a geriatric patient group in Taiwan: a 7-year survey from the outpatient clinic of a university medical center Dermatology 203 308–313 Occurrence Handle10.1159/000051778 Occurrence Handle1:STN:280:DC%2BD38%2Fgt1KmtQ%3D%3D Occurrence Handle11752818

    Article  CAS  PubMed  Google Scholar 

  • CA Frost AC Green GM Williams (1998) ArticleTitleThe prevalence and determinants of solar keratoses at a subtropical latitude (Queensland, Australia) Br J Dermatol 139 1033–1039 Occurrence Handle10.1046/j.1365-2133.1998.02560.x Occurrence Handle1:STN:280:DyaK1M7ksVWkug%3D%3D Occurrence Handle9990367

    Article  CAS  PubMed  Google Scholar 

  • ST Guenthner RM Hurwitz LJ Buckel et al. (1999) ArticleTitleCutaneous squamous cell carcinomas consistently show histologic evidence of in situ changes: a clinicopathologic correlation J Am Acad Dermatol 41 443–448 Occurrence Handle1:STN:280:DyaK1MzovFOltA%3D%3D Occurrence Handle10459120

    CAS  PubMed  Google Scholar 

  • M Lebwohl (2003) ArticleTitleActinic keratosis: epidemiology and progression to squamous cell carcinoma Br J Dermatol 149 (suppl 66) IssueIDsuppl 66 31–33 Occurrence Handle10.1046/j.0366-077X.2003.05621.x

    Article  Google Scholar 

  • EW Jeffes Suffix3rd EH Tang (2000) ArticleTitleActinic keratosis. Current treatment options Am J Clin Dermatol 1 167–179 Occurrence Handle11702298

    PubMed  Google Scholar 

  • R Marks G Rennie TS Selwood (1988) ArticleTitleMalignant transformation of solar keratoses to squamous cell carcinoma Lancet 1 795–797 Occurrence Handle10.1016/S0140-6736(88)91658-3 Occurrence Handle1:STN:280:DyaL1c7ntl2quw%3D%3D Occurrence Handle2895318

    Article  CAS  PubMed  Google Scholar 

  • SM Dinehart P Nelson-Adesokan C Cockerell et al. (1997) ArticleTitleMetastatic cutaneous squamous cell carcinoma derived from actinic keratosis Cancer 79 920–923 Occurrence Handle10.1002/(SICI)1097-0142(19970301)79:5<920::AID-CNCR8>3.0.CO;2-F Occurrence Handle1:STN:280:DyaK2s7ptlGluw%3D%3D Occurrence Handle9041154

    Article  CAS  PubMed  Google Scholar 

  • HM Ramsay AA Fryer CM Hawley et al. (2003) ArticleTitleFactors associated with nonmelanoma skin cancer following renal transplantation in Queensland, Australia J Am Acad Dermatol 49 397–406 Occurrence Handle10.1067/S0190-9622(03)00902-2 Occurrence Handle12963901

    Article  PubMed  Google Scholar 

  • J Weiss A Menter O Hevia et al. (2002) ArticleTitleEffective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeks Cutis 70 22–29 Occurrence Handle12353677

    PubMed  Google Scholar 

  • J Jorizzo D Stewart A Bucko et al. (2002) ArticleTitleRandomized trial evaluating a new 0.5% fluorouracil formulation demonstrates efficacy after 1-, 2-, or 4-week treatment in patients with actinic keratosis Cutis 70 335–339 Occurrence Handle12502122

    PubMed  Google Scholar 

  • AK Gupta JS Weiss JL Jorizzo (2001) ArticleTitle5-fluorouracil 0.5% cream for multiple actinic or solar keratoses of the face and anterior scalp Skin Therapy Lett 6 1–4 Occurrence Handle1:CAS:528:DC%2BD3MXhs12ks7g%3D Occurrence Handle11550079

    CAS  PubMed  Google Scholar 

  • JE Wolf SuffixJr JR Taylor E Tschen et al. (2001) ArticleTitleTopical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses Int J Dermatol 40 709–713 Occurrence Handle10.1046/j.1365-4362.2001.01324.x Occurrence Handle1:CAS:528:DC%2BD38XksFGhuw%3D%3D Occurrence Handle11737438

    Article  CAS  PubMed  Google Scholar 

  • DJ Piacquadio DM Chen HF Farber et al. (2004) ArticleTitlePhotodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials Arch Dermatol 140 41–46 Occurrence Handle10.1001/archderm.140.1.41 Occurrence Handle1:CAS:528:DC%2BD2cXhsVGhu78%3D Occurrence Handle14732659

    Article  CAS  PubMed  Google Scholar 

  • M Lebwohl S Dinehart D Whiting et al. (2004) ArticleTitleImiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials J Am Acad Dermatol 50 714–721 Occurrence Handle10.1016/j.jaad.2003.12.010 Occurrence Handle15097955

    Article  PubMed  Google Scholar 

  • J Jorizzo J Weiss K Furst et al. (2004) ArticleTitleOne-week treatment with topical 0.5% fluorouracil followed by adjunctive cryosurgery in treatment of actinic keratoses: six month follow-up [abstract] J Am Acad Dermatol 50 P128 Occurrence Handle10.1016/j.jaad.2003.10.439

    Article  Google Scholar 

  • KP An M Athar X Tang et al. (2002) ArticleTitleCyclooxygenase-2 expression in murine and human nonmelanoma skin cancers: implications for therapeutic approaches Photochem Photobiol 76 73–80 Occurrence Handle10.1562/0031-8655(2002)076<0073:CEIMAH>2.0.CO;2 Occurrence Handle1:CAS:528:DC%2BD38XlsV2jt7c%3D Occurrence Handle12126310

    Article  CAS  PubMed  Google Scholar 

  • JK Rivers J Arlette N Shear et al. (2002) ArticleTitleTopical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel Br J Dermatol 146 94–100 Occurrence Handle10.1046/j.1365-2133.2002.04561.x Occurrence Handle1:CAS:528:DC%2BD38Xhslaru78%3D Occurrence Handle11841372

    Article  CAS  PubMed  Google Scholar 

  • D Touma M Yaar S Whitehead et al. (2004) ArticleTitleA trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage Arch Dermatol 140 33–40 Occurrence Handle10.1001/archderm.140.1.33 Occurrence Handle1:CAS:528:DC%2BD2cXhsVGhu74%3D Occurrence Handle14732657

    Article  CAS  PubMed  Google Scholar 

  • S Smith D Piacquadio V Morhenn et al. (2003) ArticleTitleShort incubation PDT versus 5-FU in treating actinic keratoses J Drugs Dermatol 2 629–635 Occurrence Handle14711141

    PubMed  Google Scholar 

  • RM Szeimies S Karrer S Radakovic-Fijan et al. (2002) ArticleTitlePhotodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study J Am Acad Dermatol 47 258–262 Occurrence Handle10.1067/mjd.2002.119649 Occurrence Handle1:STN:280:DC%2BD38vgtFyisQ%3D%3D Occurrence Handle12140473

    Article  CAS  PubMed  Google Scholar 

  • EA Olsen L Abernethy C Kulp-Shorten et al. (1991) ArticleTitleA double-blind, vehicle-controlled study evaluating masoprostol cream in the treatment of actinic keratoses on the head and neck J Am Acad Dermatol 24 738–743 Occurrence Handle1:STN:280:DyaK3Mzjt1aisg%3D%3D Occurrence Handle1869646 Occurrence Handle10.1016/0190-9622(91)70069-E

    Article  CAS  PubMed  Google Scholar 

  • RL Miller JF Gerster ML Owens et al. (1999) ArticleTitleImiquimod applied topically: a novel immune response modifier and new class of drug Int J Immunopharmacol 21 1–14 Occurrence Handle10.1016/S0192-0561(98)00068-X Occurrence Handle1:CAS:528:DyaK1MXitFyqtLk%3D Occurrence Handle10411278

    Article  CAS  PubMed  Google Scholar 

  • LM Imbertson JM Beaurline AM Couture et al. (1998) ArticleTitleCytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463 J Invest Dermatol 110 734–739 Occurrence Handle10.1046/j.1523-1747.1998.00174.x Occurrence Handle1:CAS:528:DyaK1cXjtVGntr0%3D Occurrence Handle9579537

    Article  CAS  PubMed  Google Scholar 

  • SK Tyring I Arany MA Stanley et al. (1998) ArticleTitleA randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod J Infect Dis 178 551–555 Occurrence Handle1:CAS:528:DyaK1cXlsV2hsLc%3D Occurrence Handle9697742

    CAS  PubMed  Google Scholar 

  • I Arany SK Tyring MA Stanley et al. (1999) ArticleTitleEnhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5% Antiviral Res 43 55–63 Occurrence Handle10.1016/S0166-3542(99)00033-9 Occurrence Handle1:CAS:528:DyaK1MXksV2ktL0%3D Occurrence Handle10480263

    Article  CAS  PubMed  Google Scholar 

  • M Schön AB Bong C Drewniok et al. (2003) ArticleTitleTumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod J Natl Cancer Inst 95 1138–1149 Occurrence Handle12902443 Occurrence Handle10.1093/jnci/djg016 Occurrence Handle1:CAS:528:DC%2BD3sXmtFKrsLk%3D

    Article  PubMed  CAS  Google Scholar 

  • B Berman T Sullivan T De Araujo ParticleDe et al. (2003) ArticleTitleExpression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle Br J Dermatol 149 (suppl 66) IssueIDsuppl 66 59–61 Occurrence Handle10.1046/j.0366-077X.2003.05634.x

    Article  Google Scholar 

  • E Stockfleth T Meyer B Benninghoff et al. (2002) ArticleTitleA randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses Arch Dermatol 138 1498–1502 Occurrence Handle10.1001/archderm.138.11.1498 Occurrence Handle1:CAS:528:DC%2BD38Xpt12qurg%3D Occurrence Handle12437457

    Article  CAS  PubMed  Google Scholar 

  • E Stockfleth B Benninghoff JO Busch et al. (2004) ArticleTitleLong-term clearance of multiple actinic keratoses after topical treatment with imiquimod (5%) [abstract] J Am Acad Dermatol 50 P121 Occurrence Handle10.1016/j.jaad.2003.10.411

    Article  Google Scholar 

  • SJ Salasche N Levine L Morrison (2002) ArticleTitleCycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: an open-label trial J Am Acad Dermatol 47 571–577 Occurrence Handle10.1067/mjd.2002.126257 Occurrence Handle12271303

    Article  PubMed  Google Scholar 

  • K Chen LM Yap R Marks et al. (2003) ArticleTitleShort-course therapy with imiquimod 5% cream for solar keratoses: a randomized controlled trial Australas Dermatol 44 250–255 Occurrence Handle10.1046/j.1440-0960.2003.00003.x

    Article  Google Scholar 

  • B Berman CA Ricotti SuffixJr A Cazzaniga et al. (2004) ArticleTitleDetermination of the area of skin capable of being covered by the application of 250 mg of 5% imiquimod cream Dermatol Surg 30 784–786 Occurrence Handle10.1111/j.1524-4725.2004.30217.x Occurrence Handle15099325

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA

    Joseph L. Jorizzo

  2. Department of Dermatology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, North Carolina 27157, USA

    Joseph L. Jorizzo

Authors
  1. Joseph L. Jorizzo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joseph L. Jorizzo.

Additional information

Dr. Jorizzo is a speaker’s bureau participant for Dermik Laboratories Inc. and 3M Pharmaceuticals.

About this article

Cite this article

Jorizzo, J.L. Current and Novel Treatment Options for Actinic Keratosis. J Cutan Med Surg 8 (Suppl 3), 13–21 (2004). https://doi.org/10.1007/s10227-004-0804-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10227-004-0804-2

Keywords

Search

Navigation